"This coating dissolves in the bloodstream, enabling these two important hormones to work together in a way that mimics how they function in healthy individuals," says Eric Appel. (Credit: Getty Images) A new method could boost the effectiveness of the…
Novo Nordisk (CPSE:NOVO B) received US FDA approval for Awiqli as a once weekly basal insulin for children with type 2 diabetes. Awiqli is indicated as an adjunct to diet and exercise for patients aged 10 years and older requiring long acting…
Metformin is best known as a treatment for type 2 diabetes, but its effects on the body extend beyond lowering blood sugar. Researchers have investigated possible benefits involving weight, cardiovascular health and inflammation. The medicine helps reduce the amount of glucose…
Published October 10, 2026, in BMC Nephrology, the retrospective study examined 3,145 ICU patients with type 2 diabetes. Researchers used the MIMIC-IV database to explore whether long-term metformin use before hospitalization was associated with AKI. Of these patients, 1,245 met the study's AKI criteria, while…
New Recommendations Based on Findings from Largest-Ever International Survey of more than 13,200 Insulin-Injecting Patients from 42 Countries Sep 01, 2016, 08:59 ET FRANKLIN LAKES, N.J., Sept. 1, 2016 /PRNewswire/ -- The prestigious medical journal, Mayo Clinic Proceedings, today published new insulin delivery recommendations for health care professionals caring…
Om P. Ganda, MD, serves as chair of the Joslin Clinical Oversight Committee, and Robert A. Gabbay, MD, PhD, FACP, is senior vice president and chief medical officer of Joslin Diabetes Center. Om P. Ganda, MD Medical Director of the Lipid Clinic Robert…
Presented by: AJMC, Pharmacy Times & CancerNetwork Insulin icodec-abae becomes the first once-weekly basal insulin cleared for children 10 years and older with type 2 diabetes. Once-weekly insulin icodec-abae (Awiqli; Novo Nordisk) is now approved to improve glycemic control in children 10 years and…
Awiqli® offers children 10 years and older a once-weekly basal insulin alternative, reducing basal injection frequency from seven times per week to one1 As type 2 diabetes incidence rates among youth continue to rise,² Awiqli® may help reduce administration barriers associated with daily…
citybuzz - Neovii Pharmaceuticals AG is advancing its Type 1 Diabetes clinical program through a company-sponsored pivotal Phase 2 study in the United States and European Union, the Swiss-headquartered biopharmaceutical company announced. The expansion builds on the ongoing investigator-initiated European GIRO study and…
Conditional logistic regression analysis, LASSO feature selection, and clustering robust SE model was used for assessing AKI odds. For evaluating the incremental predictive relevance, base and augmented metformin machine learning models were developed, which included Clinical Logistic, LASSO Logistic, and…
Insulin and diabetes medicines: new drugs and approvals, weekly insulins, supply and research on treatment.
An article joins this feed when it matches these terms. Each one is also a search of its own.